Vaccine / Vaccines

Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going

Posted on: Feb 23, 2021   |   Posted by: Biotech Mag

Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going ntaylor Tue, 02/23/2021 - 08:13




Other Posts from Biotech Mag